Hapvida Shares Rise 3.4% After Positive Analyst Report
By Jeffrey T. Lewis
SÃO PAULO--Hapvida Participações e Investimentos's shares rose 3.4% after the Brazilian health insurance provider was the subject of a positive report by analysts at Itaú BBA.
Shares reached 4.59 reais, the equivalent of 93 cents, and were down 13% from the end of last year through Monday's close. Brazil's benchmark Ibovespa stocks index was up 0.8% in morning trading.
Hapvida's shares are priced at a very attractive entry point for investors after a weak recent performance, the analysts said. The company posted robust results in the second quarter, and Itaú BBA raised its projections for the insurer across the board.
Hapvida has been cautious in its approach to short-term net additions, focusing on boosting profit via price hikes and adjustments to its service-provider network. The company's cost-control efficiency should help make it the most affordable option in the industry, the analysts said.
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
September 12, 2023 10:33 ET (14:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?